About Evecxia

A privately funded clinical stage pharmaceutical company

Evecxia was co-founded by two Duke neuropsychopharmacologists, Dr. Marc Caron and Dr. Jacob Jacobsen. We are located in the Research Triangle Park, North Carolina, USA. 

Evecxia's mission is to develop and commercialize EVX-101, to treat patients suffering from disabling, common, and costly neuropsychiatric conditions in which current therapies are inadequate, in particular depression. 

Evecxia is the first company dedicated to realizing the therapeutic potential of 5-hydroxytryptophan (5-HTP) via specialized Rx combination and drug delivery dosage forms.